Kura Oncology

Kura Oncology(KURA)

SAN DIEGO, CA
Biotechnology
WebsiteLinkedInCareers Page

Focus: Small Molecules

Kura Oncology is a life sciences company focused on Small Molecules.

Oncology
Funding Stage
PUBLIC
Open Jobs
9

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT04809233Expanded Access to Tipifarnib
N/A
N/A
Clinical Trials (1)
NCT05738538Expanded Access to Ziftomenib
N/A
Phase 1
Clinical Trials (1)
NCT06397027A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
Phase 1
Phase 1
Clinical Trials (1)
NCT06448013A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
Phase 1
Phase 1
Clinical Trials (1)
NCT03051035First-in-Human Study of KO-947 in Non-Hematological Malignancies
Phase 1
Phase 1
Clinical Trials (1)
NCT07355335Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
Phase 1
Phase 1
Clinical Trials (1)
NCT04865159Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies
Phase 1
Ziftomenib
AML
Phase 1
Clinical Trials (1)
NCT06001788Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1
Phase 1
Clinical Trials (1)
NCT06026410KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Phase 1
Tipifarnib
NSCLC
Phase 1
Clinical Trials (1)
NCT05693090Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
Phase 1
Phase 1
Clinical Trials (1)
NCT06655246A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1
Phase 1
Clinical Trials (1)
NCT05735184A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Phase 1
Phase 1
Clinical Trials (1)
NCT06376162Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
Phase 1
Phase 1/2
Clinical Trials (1)
NCT05848687TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT04067336First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Phase 1/2
Tipifarnib
HNSCC
Phase 1/2
Clinical Trials (1)
NCT04997902Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Phase 1/2
Tipifarnib
Thyroid Cancer
Phase 2
Clinical Trials (1)
NCT02383927Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Phase 2
Biospecimen Collection
Acute Myeloid Leukemia
Phase 2
Clinical Trials (1)
NCT06930352Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
Phase 2
Phase 2
Clinical Trials (1)
NCT02464228Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy
Phase 2
Phase 2
Clinical Trials (1)
NCT02807272Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
Phase 2
Phase 2
Clinical Trials (1)
NCT03719690Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy
Phase 2
Phase 2
Clinical Trials (1)
NCT02779777Tipifarnib in Subjects With Myelodysplastic Syndromes
Phase 2
Phase 3
Clinical Trials (1)
NCT07007312Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3

Open Jobs (9)

Associate Director/Director, Business Development

San Diego, CA
Corporate
4d ago
$180K - $208K/yr

Scientist, Precision Medicine

San Diego, CA
Diagnostics
1w ago
$122K - $137K/yr

Head of Early Development, Caspian Therapeutics

United States
Development
1w ago
$325K - $380K/yr

Manager, IT Security Analyst

United States
IT
1w ago
$157K - $186K/yr

Associate Director, Clinical Quality Assurance

Remote
Quality Assurance
3w ago
$170K - $190K/yr

Associate Scientist

San Diego, CA
Translational Research
3w ago
$82K - $117K/yr

Director, Regulatory Affairs

Boston, Massachutsetts
Regulatory Affairs
4w ago
$226K - $259K/yr

Director, Supply Chain

Boston, MA
Manufacturing
2mo ago
$202K - $236K/yr

Senior Clinical Trial Leader

Boston, MA
Clinical Operations
4mo ago
$178K - $204K/yr
Interview Prep Quick Facts
Portfolio: 23 clinical trials
Top TAs: Oncology
SEC Filings: 2 available
Open Roles: 9 active jobs
Therapeutic Area Focus
Oncology
16 pipeline
Marketed
Pipeline

Financials (FY2025)

Revenue
$0100%
R&D Spend
$115M24%
Net Income
-$153M
Cash
$224M
Source: SEC 10-K Filing

Hiring Trend

Stable
9
Open Roles
+1
Added
-3
Filled/Removed

Based on last 4 crawl cycles